MSInsight
Created in 2022
- BETA
Up & running (A)
Existing signals show a regular activity Social networks
1,276Activities
Technologies
Entity types
Location
Paris, France
Paris
France
Employees
Scale: 2-10
Estimated: 6
SIREN
910844729Engaged corporates
32
6 31Added in Motherbase
1 year, 2 months ago
healthtech Value proposition
Unlocking the Power of Genomics: Advancing Cancer Care and Precision Medicine
MSInsight, a French health-tech company, empowers the fight against cancer by revealing actionable information from the genome. We are committed to developing a portfolio of state-of-the-art diagnostic solutions for Microsatellite Instability (MSI) status.
MSI has been shown to be an indicator of treatment response, especially for immune checkpoint inhibitors, and as an important pan-cancer biomarker.
We aim to propose bioinformatic tools for delivering insights on microsatellite mutational variations using Next-Generation Sequencing (NGS) data. Our flagship product, MSIcare, will be available as a robust diagnostic, prognostic, and theranostic assistant for guiding clinical decision-making.
Microsatellite Instability, Next-Generation Sequencing, Diagnostic Test, Bioinformatics, Oncology, Precision Medicine, Hereditary Cancer, and Defective Mismatch RepairOriginal language
Unlocking the Power of Genomics: Advancing Cancer Care and Precision Medicine
MSInsight, a French health-tech company, empowers the fight against cancer by revealing actionable information from the genome. We are committed to developing a portfolio of state-of-the-art diagnostic solutions for Microsatellite Instability (MSI) status.
MSI has been shown to be an indicator of treatment response, especially for immune checkpoint inhibitors, and as an important pan-cancer biomarker.
We aim to propose bioinformatic tools for delivering insights on microsatellite mutational variations using Next-Generation Sequencing (NGS) data. Our flagship product, MSIcare, will be available as a robust diagnostic, prognostic, and theranostic assistant for guiding clinical decision-making.
Home - MSInsight
Our mission MSInsight is empowering precision medicine in oncology by revealing actionable information on microsatellite instability - MSI - through genomic analysis. Shape the future of the diagnosis of a tumoral biomarker at the genomic level, Microsatellite Instability (MSI) Unlock a deeper and more reliable identification of MSI with genomic data from Next-Generation Sequencing Reveal
https://www.msinsight.tech/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 Ministère de l’Économie, des Finances et de la Souveraineté industrielle et numérique Government Administration | Ministère de l’Économie, des Finances et de la Souveraineté industrielle et numérique Government Administration | Other 13 Mar 2024 | | |
 France Biotech Startup accelerator & VC, Biotechnology, Biotechnology Research | France Biotech Startup accelerator & VC, Biotechnology, Biotechnology Research | Other 2 Jan 2024 | | |
 ASSOCIATION FRANCAISE DES POLES DE COMPETITIVITE French Cluster | ASSOCIATION FRANCAISE DES POLES DE COMPETITIVITE French Cluster | Other 23 Apr 2024 | | |
 Business France National and local authorities, Government Administration | Business France National and local authorities, Government Administration | Other 13 Mar 2024 | | |
 | Gouvernement | Other 6 Jul 2023 | | |
 | Ministère de la Santé | Other 6 Jul 2023 | | |
 Ministère de l'Enseignement supérieur et de la Recherche Government Administration | Ministère de l'Enseignement supérieur et de la Recherche Government Administration | Other 6 Jul 2023 | | |
 Gustave Roussy Health, Hospitals and Health Care | Gustave Roussy Health, Hospitals and Health Care | Other 19 Jul 2023 | | |
 Sanofi Pharmaceutical, Pharmaceutical Manufacturing | Sanofi Pharmaceutical, Pharmaceutical Manufacturing | Other 19 Jul 2023 | | |
 Pouss@LYS Financial Services | Pouss@LYS Financial Services | Other 10 Jul 2023 | | |